The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Two novel registry-based prediction models for overall survival in patients with metastatic esophageal or gastric cancer.
 
Héctor van den Boorn
No Relationships to Disclose
 
Ameen Abu-Hanna
Consulting or Advisory Role - ExpertDoc
 
Emil ter Veer
No Relationships to Disclose
 
Jessy Joy van Kleef
No Relationships to Disclose
 
Florian Lordick
Honoraria - AstraZeneca; BioNTech; Bristol-Myers Squibb; Elsevier; Excerpta Medica; Lilly; Medscape; Merck Sharp & Dohme
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Lilly; Merck Sharp & Dohme
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme
 
Michael Stahl
No Relationships to Disclose
 
Jaffer A. Ajani
Honoraria - Bayer; Five Prime Therapeutics; Genentech; Lilly/ImClone; Novartis; Roche/Genentech; Taiho Pharmaceutical
Research Funding - Amgen; Bristol-Myers Squibb; Delta-Fly Pharma; Gilead Sciences; Lilly/ImClone; MedImmune; Merck; Novartis; Roche/Genentech; Taiho Pharmaceutical; Takeda
Patents, Royalties, Other Intellectual Property - I have research funding from: Genentech, Roche, BMS, Taiho, MedImmune, Merck, Amgen, Lilly
Travel, Accommodations, Expenses - Bayer; Five Prime Therapeutics; Novartis
 
Rosine Guimbaud
Travel, Accommodations, Expenses - Merck Serono; Roche
 
Se Hoon Park
Consulting or Advisory Role - Lilly
Speakers' Bureau - Lilly
 
Susan J. Dutton
No Relationships to Disclose
 
Yung-Jue Bang
Consulting or Advisory Role - BeiGene; Samyang
Research Funding - AstraZeneca/MedImmune (Inst); Bayer (Inst); BeiGene (Inst); Boehringer Ingelheim (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Chong Kun Dang Pharmaceutical (Inst); Curis (Inst); Five Prime Therapeutics (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Green Cross (Inst); Lilly (Inst); Macrogenics (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Nadia Haj Mohammad
No Relationships to Disclose
 
Mirjam A.G. Sprangers
No Relationships to Disclose
 
Rob H.A. Verhoeven
No Relationships to Disclose
 
Aeilko H. Zwinderman
No Relationships to Disclose
 
Martijn G.H. van Oijen
Research Funding - Bayer (Inst); Lilly (Inst); Merck Serono (Inst); Roche (Inst)
 
Hanneke W.M. Van Laarhoven
Honoraria - Lilly/ImClone
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly/ImClone; Nordic Group
Research Funding - Bayer Schering Pharma (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Janssen-Cilag (Inst); Lilly (Inst); Nordic Group (Inst); Philips Healthcare (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca